Novartis A G (NVS)

Novartis AG (NYSE:NVS) is one of the best cheap stocks to buy for beginners. Novartis AG (NYSE:NVS) announced on June 3 new Cosentyx® data in polymyalgia rheumatica showing a statistically significant...

On June 2, Ben Snider, chief U.S.

Loomis Sayles, an investment management company, released its “Global Growth Fund” investor letter for the first quarter of 2026.  A copy of the letter is available to download here.

On May 7, NVS began construction on a 46,000-square-foot radioligand therapy manufacturing facility in Denton, Texas.

Pharmaceutical firms have always had a special place in the healthcare market because they provide stability and expansion.

The US economy is navigating a period of heightened volatility, defined by a sharp geopolitical tax on consumers and a resilient but stressed financial sector.

Novartis AG (NYSE:NVS) is one of the best pharma stocks to invest in now.

On March 24, Scott Chronert, Citi, appeared on CNBC’s 'Closing Bell' to talk about the market and whether it is time to get into equity markets.

Novartis AG (NYSE:NVS) is one of the top gene therapy stocks to buy according to hedge funds.